Username: Password:

The Infant's Dermatitis Quality of Life Index (IDQOL)

Publications describing the use

Lewis-Jones MS, Finlay AY, Dykes PJ.  Measurement of the impact of atopic dermatitis on infant’s and their families lives.  British Journal of Dermatology 1999; 141 (Suppl 55): 105-106.

1 Lewis-Jones M S, Finlay A Y, Dykes P J.  The Infants’ Dermatitis Quality of Life Index.  Br J Dermatol 2001 144: 104-10
2 Chinn D J, Poyner T, Sibley G.  Randomized controlled of a single dermatology nurse consultation in primary care on the quality of life of children with atopic eczema.  Br J Dermatol 2002; 146: 432-9.
3 Taieb C, Myon E, Perez N, Finlay A Y.  Quality of life and atopic dermatitis:  annual assessment in France. JEADV 2003; 17: 61.
4 Beattie P E, Lewis-Jones M S.  A pilot study on the use of wet wraps in moderate atopic eczema. Br J Dermatol 2003; 149 (Suppl 64):  4.
5 Taieb C, Macy G, Sibaud V, Myon E.  Atopic dermatitis and quality of life:  French evaluation in young children.  JEADV  2003; 17 (Suppl 3):  177.
6 Grad O, Niren N, Sung J, Law A.  Impact of atopic dermatitis treatment on quality of life:  Results from findings in atopic children with eczema (face) study.    J Am Acad Dermatol 2004; 50(3): P65.
7 Myon E, Taieb C, Macy G, Sibaud V.  Atopic dermatitis and patient education:  European evaluation in young children.  JEADV 2004; 18 (Suppl 1): 77.
8 Austin E, Phillips G, Lewis-Jones S.  The prevalence of fusidic acid-resistant Staphylococcus aureus colonization in paediatric outpatients with atopic dermatitis.  Br J Dermatol 151 (Suppl 68): 74.
9 Beattie P E, Lewis-Jones M S.  A pilot study on the use of wet wraps in infants with moderate atopic eczema.  Clin Exp Dermatol 2004; 29(4): 348-353.
10 Taïeb C, Macy G, Sibaud V, Myon E.  Atopic dermatitis:  European evaluation in young children.  JEADV 2004; 18 (Suppl 2) 300.
11 Beattie P E, Lewis-Jones M S.  An audit of the usefulness of quality of life measures in secondary care for assessing the impact of atopic dermatitis on infants and their families and the benefit obtained from consultation with a dermatology team.  Br J Dermatol 2005; 153 (Suppl 1): 82.
12 Beattie P E, Lewis-Jones M S.  An audit of the impact of a consultation with a paediatric dermatology team on quality of life in infants with atopic eczema and their families:  further validation of the Infants’ Dermatitis Quality of Life Index and Dermatitis Family Impact Score. Br J Dermatol 2006; 155: 1249-1255.
13 Holm E A, Esmann S, Jemec G B E.  Parent gender and assessment of infant life quality.  JEADV 2006; 20: 274-276.
14 Grillo M, Gassner L, Marshman G, Dunn S, Hudson P. Pediatric atopic eczema: the impact of an educational intervention. Pediatric Dermatology 2006; 23: 428-436.
15 Ganemo A, Svensson A, Lindberg M, Wahlgren CF. Quality of life in Swedish children with eczema. Acta Derm Venereol 2007; 87: 345-9.
16 Msika P.  New natural PPAR-a agonist for childhood atopic dermatitis:  Dermocorticoid-sparing and quality of life improvement.  J Am Acad Dermatol 2007; February AB67.
17 Grimalt R, Mengeaud V, Cambazard F. The steroid-sparing effect of an emollient therapy in infants with atopic dermatitis: a randomised controlled study. Dermatology 2007; 214: 61-67.
18 Park CK, Park CW, Lee CH. Quality of life and the family impact of atopic dermatitis in children. Korean Journal of Dermatology 2007;
19 Shaw M, Morrell D S, Goldsmith L A.  A Study of Targeted Enhanced Patient care for Pediatric Atopic Dermatitis (STEP PAD).  Pediatric Dermatology 2008; 25: 19-24.
20 Chernyshov P V.  Creation and cross-cultural adaptation of Ukrainian versions of questionnaires for assessment of quality of life of children with atopic dermatitis and their families.  Lik Sprava 2008; 1-2: 124-8.
21 McKenna SP, Doward LC. Quality of life of children with atopic dermatitis and their families. Current Opinion in Allergy and Clinical Immunology 2008; 8: 228-231.
22 Msika P, De Belilovsky C, Piccardi N, Chebassier N, Baudouin C, Chadoutaud B.  New emollient with topical corticosteroid-sparing effect in treatment of childhood atopic dermatitis: SCORAD and quality of life improved.  Pediatric Dermatology 2008; 25(6): 606-612.
23 Ahmad K, Ramsay B.  Measuring the impact on quality of life of infants with topic dermatitis in a dedicated clinic.  J Am Acad Dermatol 2009; P305, AB6.
24 Chernyshov P V.  May the gender of a parent influence assessment of health-related quality of life, family impact and severity of atopic dermatitis in children?  Pediatric Dermatology 2009; 26: 99-100.
25 Ricci G, Bendandi B, Aiazzi R, Patrizi A, Masi M.  Three years of Italian experience of an educational program for parents of young children affected by atopic dermatitis: improving knowledge produces lower anxiety levels in parents of children with atopic dermatitis. Pediatric Dermatology 2009: 26(1): 1-5.
26 Kubota Y, Yoneda K, Nakai K, Katsuura J, Moriue T, Matsuoka Y, Miyamoto I. Ohya Y.  Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study.  J Am Acad Dermatol 2009; 60(2): 212-217.
27 Tassiana MM, Alvarenga TM, Caldeira AP. Quality of life in pediatric patients with atopic dermatitis. J Pediatr (Rio J) 2009; 85: 415-20.
28 Lawrence F, Eichenfield MD, McCollum MD, Msika P. The benefits of sunflower oleodistillate (SOD) in pediatric dermatology. Pediatric Dermatology 2009; 26: 669-675,
29 Schuttelaar ML, Vermeulen KM, Drukker N, Coenraads PJ. A randomised controlled trial in children with eczema: nurse practitioner vs dermatologist. Br J Dermatol 2010; 162: 162-170.
30 Gerasimov SV, Vasjuta VV, Myhovych OO, Bondarchuk LI. Probiotic supplement reduces atopic dermatitis in preschool children: a randomised, double-blind, placebo controlled, clinical trial. Am J Clin Dermatol 2010; 11: 351-361.
31 Ho RCM, Giam YC, Ng TP, Mak A, Goh D, Zhang MWB, Cheak A, Van Bever HP. The influence of childhood atopic dermatitis on the health of mothers and its impact on Asian families. Pediatric Allergy and Immunology 2010; 21: 501-507.